Azithromycin, Ivermectin, and Hydroxychloroquine Acid for COVID-19

Azithromycin vs Ivermectin

The emergence and rapid spread of the new coronavirus, COVID-19, made doctors search for new efficient methods to deal with it. To that end, studies are being conducted to test new and already-known drugs showing good antiviral activity. Ivermectin, Hydroxychloroquine, and Azithromycin are among such medications.  

Their mechanism of action is reduced to creating an acidic environment and suppressing the activity of the virus. Experts suggest that in the future, these medications can be used for COVID-19, but as for now, their peculiarities are just being studied. It should be mentioned that neither Ivermectin nor Hydroxychloroquine nor Azithromycin haven’t been developed for a new type of coronavirus but were created for entirely different purposes.

Name of the drugIndicationsAction\Efficacy
HydroxychloroquineIs used to treat systemic lupus erythematosus and rheumatoid arthritis.The drug has anti-inflammatory and immunosuppressive properties.
 IvermectinIs used against many intestinal worms.It kills internal and external parasites by paralysing them.
AzithromycinIs used to treat acute bronchitis and pneumonia.It is an antibiotic used to treat bacterial infections.

Hydroxychloroquine, Ivermectin, and Azithromycin: What are the Prospects?

The data indicate that all three medications have been shown to have a potential broad-spectrum antiviral response and can be effective against many viruses, including COVID-19. However, possible risks connected with dosing and side effects must be taken into account. Besides, the strong demand for these drugs for treating new coronavirus and the necessity to select Azithromycin vs Ivermectin or Azithromycin for COVID-19 may lead to shortages of these drugs for the patients who use them for the intended purpose.

To include the drugs in treatment regimens for a new type of coronavirus, extensive further research must be carried out. Also, scientists must study their effects when used separately and in combination. If the research results are positive, the possibility of using Hydroxychloroquine, Ivermectin, and Azithromycin for COVID-19 treatment can be considered.

Currently, FDA doesn’t recommend using these drugs for coronavirus except for clinical studies or in a hospital setting under the supervision of specialists.

Conclusion

Experts are looking for methods of treatment for COVID-19 using new drugs and discovering new possibilities of well-known medications. Before including a drug in a treatment regimen, additional studies are required to eliminate or minimise possible adverse reactions and determine the necessary dosage.

The drugs described in this article can’t be used until further research is carried out, or they may be used in a hospital setting under the supervision of specialists.